Celcuity (CELC) Shareholder's Equity (2016 - 2025)

Celcuity (CELC) Shareholder's Equity (2016 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - 7.14 Bn
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - 795.79 Mn
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - 595,226.00
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 1.00 Bn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - 14.38 Mn
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 19.36 Bn
9 Abivax 91.71 Bn 91.71 Bn - 502.95 Mn
10 Celcuity 4.14 Bn 3.42 Bn - 100.56 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 100.56 Mn
Sep 30, 2025 116.96 Mn
Jun 30, 2025 44.38 Mn
Mar 31, 2025 86.67 Mn
Dec 31, 2024 115.62 Mn
Sep 30, 2024 149.71 Mn
Jun 30, 2024 176.69 Mn
Mar 31, 2024 133.74 Mn
Dec 31, 2023 139.77 Mn
Sep 30, 2023 92.90 Mn
Jun 30, 2023 110.13 Mn
Mar 31, 2023 123.23 Mn
Dec 31, 2022 133.77 Mn
Sep 30, 2022 43.53 Mn
Jun 30, 2022 53.19 Mn
Mar 31, 2022 61.54 Mn
Dec 31, 2021 68.71 Mn
Sep 30, 2021 74.47 Mn
Jun 30, 2021 27.03 Mn
Mar 31, 2021 35.17 Mn